Recent Finacing
Recent Raise
Salient Bio develops microbiome-based non-invasive diagnostics using its SIGNAL platform, combining automated sample processing, ML microbiome analysis, and an ISO 17025 London lab to commercialize an at-home IBD test.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
